Association of Blood Pressure Patterns in Young Adulthood With Cardiovascular Disease and Mortality in Middle Age.

Abstract:

Importance:Determining blood pressure (BP) patterns in young adulthood that are associated with cardiovascular disease (CVD) events in later life may help to identify young adults who have an increased risk for CVD. Objective:To determine whether the long-term variability of BP across clinical visits and the rate of change in BP from young adulthood to midlife are associated with CVD and all-cause mortality by middle age, independently of mean BP during young adulthood and a single BP in midlife. Design, Setting, and Participants:This prospective cohort study included a community-based sample of 3394 African American and white participants in the Coronary Artery Risk Development in Young Adults (CARDIA) Study, enrolled from March 1985 through June 1986. Patterns of systolic BP (SBP) were evaluated with measurements at year 0 (baseline) and 2, 5, 7, and 10 years after baseline. Visit-to-visit SBP variability was estimated as BP variability independent of the mean (VIM). Data were collected from March 1985 through August 2015 and analyzed from June through October 2019. Main Outcomes and Measures:Cardiovascular disease and all-cause mortality experienced through August 2015 were adjudicated. The associations of each SBP pattern with CVD events and all-cause mortality were determined using Cox proportional hazards regression models. Results:At year 10, the mean (SD) age of the 3394 participants was 35.1 (3.6) years; 1557 (45.9%) were African American; 1892 (55.7%) were women; and 103 (3.0%) were taking antihypertensive medication. During a median follow-up of 20.0 (interquartile range, 19.4-20.2) years, 162 CVD events and 181 deaths occurred. When all BP pattern measurements were entered into the same model including a single SBP measurement at the year 10 examination, the hazard ratios for CVD events for each 1-SD increase in SBP measures were 1.25 (95% CI, 0.90-1.74) for mean SBP, 1.23 (95% CI, 1.07-1.43) for VIM SBP, and 0.99 (95% CI, 0.81-1.26) for annual change of SBP. The VIM for SBP was the only BP pattern associated with all-cause mortality (hazard ratio, 1.24; 95% CI, 1.09-1.41). Conclusions and Relevance:The results of this study suggest that the assessment of visit-to-visit SBP variability may help identify young adults at increased risk for CVD and all-cause mortality later in life.

journal_name

JAMA Cardiol

journal_title

JAMA cardiology

authors

Yano Y,Reis JP,Lewis CE,Sidney S,Pletcher MJ,Bibbins-Domingo K,Navar AM,Peterson ED,Bancks MP,Kanegae H,Gidding SS,Muntner P,Lloyd-Jones DM

doi

10.1001/jamacardio.2019.5682

subject

Has Abstract

pub_date

2020-04-01 00:00:00

pages

382-389

issue

4

eissn

2380-6583

issn

2380-6591

pii

2759256

journal_volume

5

pub_type

杂志文章
  • The Burden of Cardiovascular Diseases Among US States, 1990-2016.

    abstract:Importance:Cardiovascular disease (CVD) is the leading cause of death in the United States, but regional variation within the United States is large. Comparable and consistent state-level measures of total CVD burden and risk factors have not been produced previously. Objective:To quantify and describe levels and tren...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2018.0385

    authors: Global Burden of Cardiovascular Diseases Collaboration.,Roth GA,Johnson CO,Abate KH,Abd-Allah F,Ahmed M,Alam K,Alam T,Alvis-Guzman N,Ansari H,Ärnlöv J,Atey TM,Awasthi A,Awoke T,Barac A,Bärnighausen T,Bedi N,Bennett D,

    更新日期:2018-05-01 00:00:00

  • Hybrid Positron Emission Tomography/Magnetic Resonance Imaging in Arrhythmic Mitral Valve Prolapse.

    abstract:Importance:Myocardial replacement fibrosis has been reported to occur in one-third of patients with mitral valve prolapse (MVP) and significant mitral regurgitation (MR). However, it remains unknown whether there are detectable changes in myocardial metabolism suggestive of inflammation or ischemia that accompany the d...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2020.1555

    authors: Miller MA,Adams DH,Pandis D,Robson PM,Pawale A,Pyzik R,Liao SL,El-Eshmawi A,Boateng P,Garg J,Waterford S,Weiner MM,Dukkipati SR,Reddy VY,Fayad ZA,Trivieri MG

    更新日期:2020-09-01 00:00:00

  • Assessing and Refining Myocardial Infarction Risk Estimation Among Patients With Human Immunodeficiency Virus: A Study by the Centers for AIDS Research Network of Integrated Clinical Systems.

    abstract:Importance:Persons with human immunodeficiency virus (HIV) that is treated with antiretroviral therapy have improved longevity but face an elevated risk of myocardial infarction (MI) due to common MI risk factors and HIV-specific factors. Despite these elevated MI rates, optimal methods to predict MI risks for HIV-infe...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,多中心研究

    doi:10.1001/jamacardio.2016.4494

    authors: Feinstein MJ,Nance RM,Drozd DR,Ning H,Delaney JA,Heckbert SR,Budoff MJ,Mathews WC,Kitahata MM,Saag MS,Eron JJ,Moore RD,Achenbach CJ,Lloyd-Jones DM,Crane HM

    更新日期:2017-02-01 00:00:00

  • Time-Varying Outcomes With the Absorb Bioresorbable Vascular Scaffold During 5-Year Follow-up: A Systematic Meta-analysis and Individual Patient Data Pooled Study.

    abstract:Importance:Bioresorbable scaffolds were designed to provide clinical benefits after their complete bioresorption. Prior studies demonstrated early risks with the Absorb polymeric bioresorbable vascular scaffold (BVS). Whether this risk profile changes over time during the course of its bioresorption is unknown. Object...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,meta分析

    doi:10.1001/jamacardio.2019.4101

    authors: Stone GW,Kimura T,Gao R,Kereiakes DJ,Ellis SG,Onuma Y,Chevalier B,Simonton C,Dressler O,Crowley A,Ali ZA,Serruys PW

    更新日期:2019-12-01 00:00:00

  • Use of Cardiac Resynchronization Therapy Defibrillator in US Hospitals.

    abstract:Importance:Cardiac resynchronization therapy (CRT) provides significant reduction in morbidity and mortality in select patients with left ventricular systolic dysfunction and specific parameters of electrocardiographic evidence of dyssynchrony. Relative to the 2012 American College of Cardiology/American Heart Associat...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2019.1755

    authors: Sandhu A,Bao H,Minges KE,Varosy PD,Borne RT,Zipse MM,Marzec L,Peterson P,Masoudi F,Bradley SM

    更新日期:2019-08-01 00:00:00

  • Association of Public Health Initiatives With Outcomes for Out-of-Hospital Cardiac Arrest at Home and in Public Locations.

    abstract:Importance:Little is known about the influence of comprehensive public health initiatives according to out-of-hospital cardiac arrest (OHCA) location, particularly at home, where resuscitation efforts and outcomes have historically been poor. Objective:To describe temporal trends in bystander cardiopulmonary resuscita...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2017.3471

    authors: Fordyce CB,Hansen CM,Kragholm K,Dupre ME,Jollis JG,Roettig ML,Becker LB,Hansen SM,Hinohara TT,Corbett CC,Monk L,Nelson RD,Pearson DA,Tyson C,van Diepen S,Anderson ML,McNally B,Granger CB

    更新日期:2017-11-01 00:00:00

  • Assessing Cardiovascular Risk to Guide Hypertension Diagnosis and Treatment.

    abstract:Importance:The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated the benefit of lowering systolic blood pressure (SBP) to 120 mm Hg, yet other trials, such as Heart Outcomes Prevention Evaluation-3 (HOPE-3), did not find consistent benefit. How to incorporate these results into the treatment of those wit...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2016.2861

    authors: Navar AM,Pencina MJ,Peterson ED

    更新日期:2016-11-01 00:00:00

  • Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.

    abstract:Importance:Somatic mutations causing clonal expansion of hematopoietic cells (clonal hematopoiesis of indeterminate potential [CHIP]) are increased with age and associated with atherosclerosis and inflammation. Age and inflammation are the major risk factors for heart failure, yet the association of CHIP with heart fai...

    journal_title:JAMA cardiology

    pub_type: 临床试验,杂志文章

    doi:10.1001/jamacardio.2018.3965

    authors: Dorsheimer L,Assmus B,Rasper T,Ortmann CA,Ecke A,Abou-El-Ardat K,Schmid T,Brüne B,Wagner S,Serve H,Hoffmann J,Seeger F,Dimmeler S,Zeiher AM,Rieger MA

    更新日期:2019-01-01 00:00:00

  • Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and Mortality: The Atherosclerosis Risk in Communities (ARIC) Study.

    abstract:IMPORTANCE:The adverse outcomes associated with atrial fibrillation (AF) have been studied in predominantly white cohorts. Racial differences in outcomes associated with AF merit continued investigation. OBJECTIVE:To evaluate the race-specific associations of AF with stroke, heart failure, coronary heart disease (CHD)...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2016.1025

    authors: Magnani JW,Norby FL,Agarwal SK,Soliman EZ,Chen LY,Loehr LR,Alonso A

    更新日期:2016-07-01 00:00:00

  • Association of Maternal Prepregnancy Dyslipidemia With Adult Offspring Dyslipidemia in Excess of Anthropometric, Lifestyle, and Genetic Factors in the Framingham Heart Study.

    abstract:IMPORTANCE:Dyslipidemia in young adults in the United States during their childbearing years is common, and the consequences for the next generation are poorly understood. Further understanding of the harmful consequences of elevated low-density lipoprotein cholesterol (LDL-C) levels in young adults may help to inform ...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2015.0304

    authors: Mendelson MM,Lyass A,O'Donnell CJ,D'Agostino RB Sr,Levy D

    更新日期:2016-04-01 00:00:00

  • Trends in Utilization and Cost of Low-Density Lipoprotein Cholesterol-Lowering Therapies Among Medicare Beneficiaries: An Analysis From the Medicare Part D Database.

    abstract:Importance:Low-density lipoprotein cholesterol (LDL-C)-lowering therapies are a cornerstone of prevention in atherosclerotic cardiovascular disease. With the introduction of generic formulations and the release of new therapies, including proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, contemporary Me...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2020.3723

    authors: Sumarsono A,Lalani HS,Vaduganathan M,Navar AM,Fonarow GC,Das SR,Pandey A

    更新日期:2021-01-01 00:00:00

  • Association Between Circulating Baseline Proprotein Convertase Subtilisin Kexin Type 9 Levels and Efficacy of Evolocumab.

    abstract:Importance:Levels of proprotein convertase subtilisin kexin type 9 (PCSK9) vary markedly across the population and are influenced by genetic and nongenetic factors. Evolocumab is a fully human, monoclonal antibody against PCSK9 that reduces low-density lipoprotein cholesterol (LDL-C) levels by 55% to 75%. Whether the e...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2016.5395

    authors: Desai NR,Giugliano RP,Wasserman SM,Gibbs JP,Liu T,Scott R,Sabatine MS

    更新日期:2017-05-01 00:00:00

  • Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial.

    abstract:Importance:Sustained reductions in low-density lipoprotein cholesterol (LDL-C) with lipid-lowering therapies that require frequent dosing are reliant on patient adherence, and poor adherence is associated with worse clinical outcomes. Objective:To determine whether inclisiran, a small interfering RNA, reduces mean LDL...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,随机对照试验

    doi:10.1001/jamacardio.2019.3502

    authors: Ray KK,Stoekenbroek RM,Kallend D,Nishikido T,Leiter LA,Landmesser U,Wright RS,Wijngaard PLJ,Kastelein JJP

    更新日期:2019-11-01 00:00:00

  • Association of Baseline Low-Density Lipoprotein Cholesterol and Percentage Low-Density Lipoprotein Cholesterol Reduction With Statins, Ezetimibe, and PCSK9 Inhibition.

    abstract:Importance:Low-density lipoprotein cholesterol (LDL-C) is an important modifiable risk factor for atherosclerotic cardiovascular disease. It is unclear whether the percentage LDL-C lowering with pharmacotherapies differs on the basis of baseline LDL-C levels. Objective:To evaluate the association between baseline LDL-...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2020.6184

    authors: Marcusa DP,Giugliano RP,Park JG,de Lemos JA,Cannon CP,Sabatine MS

    更新日期:2020-11-13 00:00:00

  • Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study.

    abstract:Importance:With improved survival, heart failure (HF) has become a major complication for individuals with human immunodeficiency virus (HIV) infection. It is unclear if this risk extends to different types of HF in the antiretroviral therapy (ART) era. Determining whether HIV infection is associated with HF with reduc...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2017.0264

    authors: Freiberg MS,Chang CH,Skanderson M,Patterson OV,DuVall SL,Brandt CA,So-Armah KA,Vasan RS,Oursler KA,Gottdiener J,Gottlieb S,Leaf D,Rodriguez-Barradas M,Tracy RP,Gibert CL,Rimland D,Bedimo RJ,Brown ST,Goetz MB,Warner

    更新日期:2017-05-01 00:00:00

  • Sudden Cardiac Arrest Risk Assessment: Population Science and the Individual Risk Mandate.

    abstract:Importance:High-resolution stratification of risk of sudden cardiac arrest (SCA) in individual patients is a tool that is necessary for achieving effective and efficient application of data generated by population-based research. This concept is at the core of initiatives for merging cost effectiveness with maximized c...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,评审

    doi:10.1001/jamacardio.2017.0266

    authors: Myerburg RJ,Goldberger JJ

    更新日期:2017-06-01 00:00:00

  • Long-term Outcomes Associated With Total Arterial Revascularization vs Non-Total Arterial Revascularization.

    abstract:Importance:The optimal conduits for coronary artery bypass grafting (CABG) remain controversial in multivessel coronary artery disease. Objective:To compare the long-term clinical outcomes of total arterial revascularization (TAR) vs non-TAR (CABG with at least 1 arterial and 1 saphenous vein graft) in a multicenter p...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,多中心研究

    doi:10.1001/jamacardio.2019.6104

    authors: Rocha RV,Tam DY,Karkhanis R,Wang X,Austin PC,Ko DT,Gaudino M,Royse A,Fremes SE

    更新日期:2020-05-01 00:00:00

  • Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment Study : A Randomized Clinical Trial.

    abstract:Importance:Cohort studies have reported increased incidence of cardiovascular disease (CVD) among individuals with low vitamin D status. To date, randomized clinical trials of vitamin D supplementation have not found an effect, possibly because of using too low a dose of vitamin D. Objective:To examine whether monthly...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,随机对照试验

    doi:10.1001/jamacardio.2017.0175

    authors: Scragg R,Stewart AW,Waayer D,Lawes CMM,Toop L,Sluyter J,Murphy J,Khaw KT,Camargo CA Jr

    更新日期:2017-06-01 00:00:00

  • Rates of Invasive Management of Cardiogenic Shock in New York Before and After Exclusion From Public Reporting.

    abstract:IMPORTANCE:Reduced rates of cardiac catheterization, percutaneous coronary intervention (PCI), and coronary artery bypass graft (CABG) are an unintended consequence of public reporting of cardiogenic shock outcomes in New York. OBJECTIVES:To evaluate whether the referral rates for cardiac catheterization, PCI, or CABG...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2016.0785

    authors: Bangalore S,Guo Y,Xu J,Blecker S,Gupta N,Feit F,Hochman JS

    更新日期:2016-09-01 00:00:00

  • Sex Differences in Blood Pressure Trajectories Over the Life Course.

    abstract:Importance:If we assume that women and men exhibit variations of the same fundamental vascular physiology, then conventional analyses of subclinical measures would suggest that women catch up to men by midlife in the extent of potentially important vascular disease. Alternatively, under the assumption that vascular phy...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2019.5306

    authors: Ji H,Kim A,Ebinger JE,Niiranen TJ,Claggett BL,Bairey Merz CN,Cheng S

    更新日期:2020-03-01 00:00:00

  • Adjunctive Antithrombotic Therapy for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.

    abstract:Importance:Transcatheter aortic valve replacement (TAVR) is an established alternative to surgery for patients with severe symptomatic aortic stenosis. Adjunctive antithrombotic therapy used to mitigate thrombotic risks in patients undergoing TAVR must be balanced against bleeding complications, since both are associat...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,评审

    doi:10.1001/jamacardio.2019.4367

    authors: Saito Y,Nazif T,Baumbach A,Tchétché D,Latib A,Kaple R,Forrest J,Prendergast B,Lansky A

    更新日期:2020-01-01 00:00:00

  • Comparison of Approaches for Heart Failure Case Identification From Electronic Health Record Data.

    abstract:Importance:Accurate, real-time case identification is needed to target interventions to improve quality and outcomes for hospitalized patients with heart failure. Problem lists may be useful for case identification but are often inaccurate or incomplete. Machine-learning approaches may improve accuracy of identificatio...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2016.3236

    authors: Blecker S,Katz SD,Horwitz LI,Kuperman G,Park H,Gold A,Sontag D

    更新日期:2016-12-01 00:00:00

  • Diagnostic Accuracy of Computed Tomography-Derived Fractional Flow Reserve : A Systematic Review.

    abstract:Importance:Computed tomography-derived fractional flow reserve (FFR-CT) is a novel, noninvasive test for myocardial ischemia. Clinicians using FFR-CT must be able to interpret individual FFR-CT results to determine subsequent patient care. Objective:To provide clinicians a means of interpreting individual FFR-CT resul...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2017.1314

    authors: Cook CM,Petraco R,Shun-Shin MJ,Ahmad Y,Nijjer S,Al-Lamee R,Kikuta Y,Shiono Y,Mayet J,Francis DP,Sen S,Davies JE

    更新日期:2017-07-01 00:00:00

  • Association Between Reproductive Life Span and Incident Nonfatal Cardiovascular Disease: A Pooled Analysis of Individual Patient Data From 12 Studies.

    abstract:Importance:Early menarche and early menopause are associated with increased risk of cardiovascular disease (CVD) in midlife, but little is known about the association between reproductive life span and the risk of CVD. Objective:To investigate the association between the length of reproductive life span and risk of in...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2020.4105

    authors: Mishra SR,Chung HF,Waller M,Dobson AJ,Greenwood DC,Cade JE,Giles GG,Bruinsma F,Simonsen MK,Hardy R,Kuh D,Gold EB,Crawford SL,Derby CA,Matthews KA,Demakakos P,Lee JS,Mizunuma H,Hayashi K,Sievert LL,Brown DE,Sandi

    更新日期:2020-09-16 00:00:00

  • Association of Oral Contraceptives With Drug-Induced QT Interval Prolongation in Healthy Nonmenopausal Women.

    abstract:Importance:Women are at higher risk of drug-induced torsade de pointes (TdP) than men. Androgens are protective. Influence of oral contraception on drug-induced TdP and QT prolongation is controversial. Objective:To determine if the extent of sotalol-induced corrected QT (QTc) prolongation and specific T-wave morpholo...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2018.2251

    authors: Salem JE,Dureau P,Bachelot A,Germain M,Voiriot P,Lebourgeois B,Trégouët DA,Hulot JS,Funck-Brentano C

    更新日期:2018-09-01 00:00:00

  • Association of Echocardiographic Left Ventricular End-Systolic Volume and Volume-Derived Ejection Fraction With Outcome in Asymptomatic Chronic Aortic Regurgitation.

    abstract:Importance:Volumetric measurements by transthoracic echocardiogram may better reflect left ventricular (LV) remodeling than conventional linear LV dimensions. However, the association of LV volumes with mortality in patients with chronic hemodynamically significant aortic regurgitation (AR) is unknown. Objective:To as...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2020.5268

    authors: Yang LT,Anand V,Zambito EI,Pellikka PA,Scott CG,Thapa P,Padang R,Takeuchi M,Nishimura RA,Enriquez-Sarano M,Michelena HI

    更新日期:2020-11-04 00:00:00

  • Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.

    abstract:Importance:Transthyretin cardiac amyloidosis (also known as ATTR cardiac amyloidosis) is an increasingly recognized cause of heart failure with preserved ejection fraction. In single-center studies, technetium 99m pyrophosphate (Tc 99m PYP) cardiac imaging noninvasively detects ATTR cardiac amyloidosis, but the accurac...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,多中心研究

    doi:10.1001/jamacardio.2016.2839

    authors: Castano A,Haq M,Narotsky DL,Goldsmith J,Weinberg RL,Morgenstern R,Pozniakoff T,Ruberg FL,Miller EJ,Berk JL,Dispenzieri A,Grogan M,Johnson G,Bokhari S,Maurer MS

    更新日期:2016-11-01 00:00:00

  • Differences in Management of Coronary Artery Disease in Patients With Medicare Advantage vs Traditional Fee-for-Service Medicare Among Cardiology Practices.

    abstract:Importance:One-third of Medicare beneficiaries are enrolled in Medicare Advantage (MA), Medicare's private plan option. Medicare Advantage incentivizes performance on evidence-based care, but limited information exists using reliable clinical data to determine whether this translates into better quality for patients wi...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2019.0007

    authors: Figueroa JF,Blumenthal DM,Feyman Y,Frakt AB,Turchin A,Doros G,Gao Q,Song Y,Joynt Maddox KE

    更新日期:2019-03-01 00:00:00

  • Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial.

    abstract:Importance:Limited evidence is available regarding the benefit and hazard of higher-intensity treatment to lower lipid levels among patients 75 years or older. As a result, guideline recommendations differ for this age group compared with younger patients. Objective:To determine the effect on outcomes and risks of com...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1001/jamacardio.2019.2306

    authors: Bach RG,Cannon CP,Giugliano RP,White JA,Lokhnygina Y,Bohula EA,Califf RM,Braunwald E,Blazing MA

    更新日期:2019-09-01 00:00:00

  • Effects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure: Proposal of a Novel Mechanism of Action.

    abstract:Importance:Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducing the risk of the development or progression of heart failure. In a landmark trial called Empagliflozin, Cardiovascular Outcomes, and M...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2017.2275

    authors: Packer M,Anker SD,Butler J,Filippatos G,Zannad F

    更新日期:2017-09-01 00:00:00